Podcast
Questions and Answers
What is the primary challenge in differentiating post-therapy changes from residual viable tumor tissue?
What is the primary challenge in differentiating post-therapy changes from residual viable tumor tissue?
- Limited availability of radiopharmaceuticals
- High cost of PET scans
- Difficulty in interpreting MRI and CT scans (correct)
- Insufficient training of radiologists
What is the role of PET scans in detecting tumor recurrence?
What is the role of PET scans in detecting tumor recurrence?
- To confirm the diagnosis of a new tumor
- To monitor the effectiveness of chemotherapy
- To detect the presence of metastasis
- To differentiate tumor recurrence from necrosis (correct)
What is the significance of radiopharmaceuticals in different malignancies?
What is the significance of radiopharmaceuticals in different malignancies?
- They play an important role in detecting recurrence (correct)
- They are used to monitor the effectiveness of radiation therapy
- They are used to treat cancer
- They are used to diagnose cancer
What is the advantage of using F-18-FDG-PET/CT scans in detecting recurrent tumor?
What is the advantage of using F-18-FDG-PET/CT scans in detecting recurrent tumor?
What is the purpose of performing follow-up F-18-FDG-PET/CT studies?
What is the purpose of performing follow-up F-18-FDG-PET/CT studies?
What is the limitation of MRI and CT scans in differentiating post-therapy changes?
What is the limitation of MRI and CT scans in differentiating post-therapy changes?
Which of the following is an example of a radiopharmaceutical?
Which of the following is an example of a radiopharmaceutical?
What does the follow-up F-18-FDG-PET/CT study in the given image show?
What does the follow-up F-18-FDG-PET/CT study in the given image show?
Why is PET scan used in detecting tumor recurrence?
Why is PET scan used in detecting tumor recurrence?
What is the importance of identifying viable tumors by imaging?
What is the importance of identifying viable tumors by imaging?